RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/29769201http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/29769201http://www.w3.org/2000/01/rdf-schema#comment"Adoptive T-cell transfer therapy is an FDA-approved treatment for leukemia that relies on the ex vivo expansion and reinfusion of a patient's immune cells, which can be engineered with a chimeric antigen receptor (CAR) for more efficient tumor recognition. Type 17 T cells, controlled transcriptionally by RORγ, have been reported to mediate potent antitumor effects superior to those observed with conventionally expanded T cells. Here, we demonstrate that addition of a synthetic, small-molecule RORγ agonist during ex vivo expansion potentiates the antitumor activity of human Th17 and Tc17 cells redirected with a CAR. Likewise, ex vivo use of this agonist bolstered the antitumor properties of murine tumor-specific CD4+ and CD8+ T cells. Expansion in the presence of the RORγ agonist enhanced IL17A production without compromising IFNγ secretion in vitroIn vivo, cytokine neutralization studies revealed that IFNγ and IL17A were required to regress murine melanoma tumors. The enhanced antitumor effect of RORγ agonist treatment was associated with recovery of more donor T cells in the tumor and spleen; these cells produced elevated levels of cytokines months after infusion and expressed markers of long-lived stem and central memory cells such as Tcf7 and CD62L. Conversely, untreated cells mainly exhibited effector phenotypes in the tumor. Cured mice previously treated with agonist-primed T cells were protected from tumor rechallenge. Collectively, our work reveals that in vitro treatment with a RORγ agonist generates potent antitumor Type 17 effector cells that persist as long-lived memory cells in vivoSignificance: RORγ agonists can be used in vitro during T-cell expansion to enhance the efficacy of adoptive cell therapy (e.g., CAR-T) and to provide long-term protection against tumors.Graphical Abstract: http://cancerres.aacrjournals.org/content/canres/78/14/3888/F1.large.jpg Cancer Res; 78(14); 3888-98. ©2018 AACR."xsd:string
http://purl.uniprot.org/citations/29769201http://purl.org/dc/terms/identifier"doi:10.1158/0008-5472.can-17-3973"xsd:string
http://purl.uniprot.org/citations/29769201http://purl.uniprot.org/core/author"Hu X."xsd:string
http://purl.uniprot.org/citations/29769201http://purl.uniprot.org/core/author"Liu X."xsd:string
http://purl.uniprot.org/citations/29769201http://purl.uniprot.org/core/author"Zou W."xsd:string
http://purl.uniprot.org/citations/29769201http://purl.uniprot.org/core/author"Carter L.L."xsd:string
http://purl.uniprot.org/citations/29769201http://purl.uniprot.org/core/author"Moisan J."xsd:string
http://purl.uniprot.org/citations/29769201http://purl.uniprot.org/core/author"Paulos C.M."xsd:string
http://purl.uniprot.org/citations/29769201http://purl.uniprot.org/core/author"Spooner C.J."xsd:string
http://purl.uniprot.org/citations/29769201http://purl.uniprot.org/core/author"Majchrzak K."xsd:string
http://purl.uniprot.org/citations/29769201http://purl.uniprot.org/core/author"Wyatt M.M."xsd:string
http://purl.uniprot.org/citations/29769201http://purl.uniprot.org/core/date"2018"xsd:gYear
http://purl.uniprot.org/citations/29769201http://purl.uniprot.org/core/name"Cancer Res"xsd:string
http://purl.uniprot.org/citations/29769201http://purl.uniprot.org/core/pages"3888-3898"xsd:string
http://purl.uniprot.org/citations/29769201http://purl.uniprot.org/core/title"pii>In Vitropi/i> Priming of Adoptively Transferred T Cells with a RORgamma Agonist Confers Durable Memory and Stemness pii>In Vivopi/i>."xsd:string
http://purl.uniprot.org/citations/29769201http://purl.uniprot.org/core/volume"78"xsd:string
http://purl.uniprot.org/citations/29769201http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/29769201
http://purl.uniprot.org/citations/29769201http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/29769201
http://purl.uniprot.org/uniprot/#_A0A0G2JGZ6-mappedCitation-29769201http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/29769201
http://purl.uniprot.org/uniprot/#_A0A0R4J096-mappedCitation-29769201http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/29769201
http://purl.uniprot.org/uniprot/#_Q3UUW3-mappedCitation-29769201http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/29769201
http://purl.uniprot.org/uniprot/#_P51450-mappedCitation-29769201http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/29769201
http://purl.uniprot.org/uniprot/#_Q3TVH3-mappedCitation-29769201http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/29769201
http://purl.uniprot.org/uniprot/A0A0G2JGZ6http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/29769201